This inventor holds 32 USPTO granted patents and 7 published patent applications, plus 5 CIPO patents and 3 EPO patents, primarily in Cancer Diagnostics. Top assignees: Oncogen, Bristol-Myers Squibb Compnay, Pacific Northwest Research Institute. Active years: 1988-2017.
Company Filing History:
16 out of 48 
6 out of 3,736 
4 out of 9 
Years Active: 1988-2017
Areas of Expertise:
Title: Ingegerd E Hellstrom: Pioneering Innovations in Ovarian Cancer Diagnosis
Introduction: Ingegerd E Hellstrom is a notable inventor based in Seattle, Washington, with a significant contribution to the field of cancer research. With a remarkable portfolio of 32 patents, Hellstrom has dedicated her work to developing innovative methods and compositions for the diagnosis and treatment of ovarian cancer. Her research has paved the way for advancements in early detection and patient management.
Latest Patents: Among Hellstrom's latest patents is a groundbreaking invention titled "Compositions and methods of use for determination of HE4a." This invention focuses on utilizing HE/HE4a markers to assess ovarian cancer in subjects, including methods for diagnosis, grading, staging, and evaluating prognosis and treatment effectiveness. Another notable patent, "Diagnosis of carcinomas," directs attention to compositions and methods for detecting malignant conditions. It encompasses the discovery of soluble and cell surface forms of the HE4a polypeptide, which is known to be overexpressed in ovarian carcinomas. This patent also offers a nucleic acid sequence encoding HE4a and describes a method to screen for malignant conditions by identifying reactivity of antibodies specific to HE4a polypeptides in samples from subjects.
Career Highlights: Ingegerd E Hellstrom has had a distinguished career, having worked with prominent organizations such as Oncogen and Bristol-Myers Squibb Company. Her roles in these companies have allowed her to leverage her expertise in cancer diagnostics and therapeutics, contributing to significant advancements in the field.
Collaborations: Throughout her career, Hellstrom has collaborated with esteemed colleagues, including Karl E Hellstrom and Joseph P Brown. These partnerships have fostered innovation and have been instrumental in advancing the research and applications of her inventions.
Conclusion: Ingegerd E Hellstrom's work represents a vital contribution to the fight against ovarian cancer. Her innovative patents and collaborations have the potential to improve diagnosis and treatment outcomes for patients. With her extensive experience and continued dedication, Hellstrom remains an influential figure in cancer research and diagnostics.